While maintaining the leading position in R&D, Venturepharm provides full-range of pharmaceutical development services by integrating companies of R&D, manufacturing and sales/marketing through alliance and cooperation. Meanwhile, Venturepharm actively exploits the oversea markets of R&D outsourcing service. With its breadth of capabilities, Venturepharm provides comprehensive service to our clients with efficiency and simplicity of working with one company that meets various kinds of needs.  As a result we can bring high investment returns to our shareholders.

· R&D leader       

Venturepharm’s core competency is focused at new drug R&D, with multidisciplinary expertise in new drug R&D driven by a force of over 300 international scientists. It also possesses an extensive network of international and domestic specialists in new drug development outsourcing, providing integrated pharmaceutical services that include new drug research, drug delivery, clinical research, product registration and marketing & sales.

·Comprehensive Network of Full Pharmaceutical Services
Venturepharm has established a network of R&D and manufacturing facilities throughout the world, with eight R&D centers, three GMP integrated manufacturing facilities and four bulk API manufacturing facilities, of which two are approved and certified by US FDA.

·Expedited Support of Capital Market
The smooth capital market channel enables Venturepharm to integrate its leading R&D technology with capital market to create the synergized value for both technology and capital.